Analyst Sumant Kulkarni works at CANACCORD and is covering the the Healthcare sector with 247 price targets and ratings documented since 2012 spanning on 16 stocks.
Sumant Kulkarni's average stock forecast success ratio is 37.21% with an average time for price targets to be met of 191.38 days.
Most recent stock forecast was given on VYGR, Voyager Therapeutics, Inc at 10-May-2023.
Analyst best performing recommendations are on VYGR (VOYAGER THERAPEUTICS, INC).
The best stock recommendation documented was for BTAI (BIOXCEL THERAPEUTICS, INC) at 10/7/2019. The price target of $24 was fulfilled within 130 days with a profit of $17.54 (271.52%) receiving and performance score of 20.89.
Average potential price target upside
Currently, out of the existing stock ratings of Sumant Kulkarni - 8 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
26
$2.03 (8.47%)
32
15 days ago
4/7 (57.14%)
$6.71 (26.73%)
285
Buy
28
$4.03 (16.81%)
28
28 days ago
5/10 (50%)
$9.79 (40.33%)
175
Buy
23
$-0.97 (-4.05%)
35
28 days ago
8/14 (57.14%)
$11.27 (50.83%)
188
Buy
27
$3.03 (12.64%)
27
28 days ago
3/15 (20%)
$9.76 (40.41%)
186
Hold
20
$-3.97 (-16.56%)
20
1 months 23 days ago
7/11 (63.64%)
$3.28 (11.66%)
51
